Robert Burns
Stock Analyst at HC Wainwright & Co.
(1.01)
# 3,635
Out of 4,761 analysts
479
Total ratings
26.47%
Success rate
-18.01%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Robert Burns
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SWTX SpringWorks Therapeutics | Reiterates: Buy | $74 | $58.25 | +27.04% | 30 | Feb 21, 2025 | |
| REPL Replimune Group | Maintains: Buy | $21 → $22 | $13.98 | +57.37% | 16 | Feb 13, 2025 | |
| EXEL Exelixis | Reiterates: Buy | $40 | $36.85 | +8.55% | 6 | Feb 13, 2025 | |
| ORIC ORIC Pharmaceuticals | Reiterates: Buy | $21 | $7.68 | +173.44% | 19 | Feb 11, 2025 | |
| IMMX Immix Biopharma | Reiterates: Buy | $7 | $1.76 | +297.73% | 7 | Feb 10, 2025 | |
| CRGX CARGO Therapeutics | Downgrades: Neutral | n/a | $3.77 | - | 4 | Jan 30, 2025 | |
| NRIX Nurix Therapeutics | Maintains: Buy | $35 → $36 | $16.87 | +113.40% | 14 | Jan 29, 2025 | |
| ATRA Atara Biotherapeutics | Reiterates: Neutral | n/a | $7.11 | - | 13 | Jan 28, 2025 | |
| BCAX Bicara Therapeutics | Maintains: Buy | $42 → $45 | $13.00 | +246.15% | 2 | Jan 27, 2025 | |
| NUVB Nuvation Bio | Maintains: Buy | $10 → $11 | $2.21 | +397.74% | 13 | Jan 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $36 → $39 | $27.07 | +44.07% | 7 | Jan 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $17 → $14 | $8.00 | +75.00% | 10 | Jan 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $16 | $3.92 | +308.16% | 20 | Jan 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $22 | $5.72 | +284.62% | 19 | Jan 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $8 | $1.63 | +390.80% | 20 | Jan 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $64 → $72 | $41.34 | +74.17% | 18 | Dec 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | $12 | $14.39 | -16.61% | 19 | Nov 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $150 | $120.01 | +24.99% | 37 | Nov 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $9 | $1.31 | +587.02% | 12 | Nov 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $40 | $5.46 | +632.60% | 2 | Nov 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $13 | $2.36 | +450.85% | 11 | Nov 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $9 | $2.17 | +314.75% | 16 | Nov 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $5 | $0.87 | +474.12% | 14 | Nov 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $1.29 | +675.19% | 17 | Nov 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | $4 | $2.76 | +44.93% | 20 | Nov 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $11 | $2.16 | +409.26% | 12 | Nov 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $37 | $21.80 | +69.72% | 2 | Oct 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $12 → $11 | $1.38 | +697.10% | 13 | Sep 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $8.54 | +17.10% | 6 | Aug 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $2.79 | - | 11 | Aug 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $5 | $1.41 | +254.61% | 10 | Aug 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $2.25 | $1.00 | +125.00% | 10 | Aug 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $12 | $0.16 | +7,404.69% | 9 | Aug 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $500 → $200 | $7.02 | +2,749.00% | 5 | May 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $110 → $20 | $1.05 | +1,804.76% | 2 | Mar 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $4.57 | - | 6 | Jan 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $150 | $2.15 | +6,876.74% | 6 | Aug 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $22 | $1.39 | +1,482.73% | 4 | Mar 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $115 → $7 | $1.42 | +392.96% | 7 | Jan 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $12 → $11 | $0.78 | +1,310.26% | 1 | Dec 22, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $250 → $225 | $1.09 | +20,542.20% | 7 | Nov 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $25 | $4.68 | +434.07% | 1 | Jun 21, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $19 → $13 | $1.95 | +566.67% | 1 | Jan 7, 2021 |
SpringWorks Therapeutics
Feb 21, 2025
Reiterates: Buy
Price Target: $74
Current: $58.25
Upside: +27.04%
Replimune Group
Feb 13, 2025
Maintains: Buy
Price Target: $21 → $22
Current: $13.98
Upside: +57.37%
Exelixis
Feb 13, 2025
Reiterates: Buy
Price Target: $40
Current: $36.85
Upside: +8.55%
ORIC Pharmaceuticals
Feb 11, 2025
Reiterates: Buy
Price Target: $21
Current: $7.68
Upside: +173.44%
Immix Biopharma
Feb 10, 2025
Reiterates: Buy
Price Target: $7
Current: $1.76
Upside: +297.73%
CARGO Therapeutics
Jan 30, 2025
Downgrades: Neutral
Price Target: n/a
Current: $3.77
Upside: -
Nurix Therapeutics
Jan 29, 2025
Maintains: Buy
Price Target: $35 → $36
Current: $16.87
Upside: +113.40%
Atara Biotherapeutics
Jan 28, 2025
Reiterates: Neutral
Price Target: n/a
Current: $7.11
Upside: -
Bicara Therapeutics
Jan 27, 2025
Maintains: Buy
Price Target: $42 → $45
Current: $13.00
Upside: +246.15%
Nuvation Bio
Jan 23, 2025
Maintains: Buy
Price Target: $10 → $11
Current: $2.21
Upside: +397.74%
Jan 22, 2025
Maintains: Buy
Price Target: $36 → $39
Current: $27.07
Upside: +44.07%
Jan 14, 2025
Maintains: Buy
Price Target: $17 → $14
Current: $8.00
Upside: +75.00%
Jan 14, 2025
Reiterates: Buy
Price Target: $16
Current: $3.92
Upside: +308.16%
Jan 13, 2025
Reiterates: Buy
Price Target: $22
Current: $5.72
Upside: +284.62%
Jan 6, 2025
Reiterates: Buy
Price Target: $8
Current: $1.63
Upside: +390.80%
Dec 4, 2024
Maintains: Buy
Price Target: $64 → $72
Current: $41.34
Upside: +74.17%
Nov 22, 2024
Reiterates: Neutral
Price Target: $12
Current: $14.39
Upside: -16.61%
Nov 18, 2024
Reiterates: Buy
Price Target: $150
Current: $120.01
Upside: +24.99%
Nov 15, 2024
Reiterates: Buy
Price Target: $9
Current: $1.31
Upside: +587.02%
Nov 8, 2024
Reiterates: Buy
Price Target: $40
Current: $5.46
Upside: +632.60%
Nov 8, 2024
Reiterates: Buy
Price Target: $13
Current: $2.36
Upside: +450.85%
Nov 8, 2024
Reiterates: Buy
Price Target: $9
Current: $2.17
Upside: +314.75%
Nov 8, 2024
Reiterates: Buy
Price Target: $5
Current: $0.87
Upside: +474.12%
Nov 8, 2024
Reiterates: Buy
Price Target: $10
Current: $1.29
Upside: +675.19%
Nov 6, 2024
Reiterates: Neutral
Price Target: $4
Current: $2.76
Upside: +44.93%
Nov 6, 2024
Reiterates: Buy
Price Target: $11
Current: $2.16
Upside: +409.26%
Oct 1, 2024
Reiterates: Buy
Price Target: $37
Current: $21.80
Upside: +69.72%
Sep 5, 2024
Maintains: Neutral
Price Target: $12 → $11
Current: $1.38
Upside: +697.10%
Aug 23, 2024
Reiterates: Buy
Price Target: $10
Current: $8.54
Upside: +17.10%
Aug 21, 2024
Reiterates: Neutral
Price Target: n/a
Current: $2.79
Upside: -
Aug 20, 2024
Reiterates: Buy
Price Target: $5
Current: $1.41
Upside: +254.61%
Aug 19, 2024
Reiterates: Buy
Price Target: $2.25
Current: $1.00
Upside: +125.00%
Aug 15, 2024
Reiterates: Buy
Price Target: $12
Current: $0.16
Upside: +7,404.69%
May 8, 2024
Maintains: Buy
Price Target: $500 → $200
Current: $7.02
Upside: +2,749.00%
Mar 21, 2024
Maintains: Buy
Price Target: $110 → $20
Current: $1.05
Upside: +1,804.76%
Jan 8, 2024
Downgrades: Neutral
Price Target: n/a
Current: $4.57
Upside: -
Aug 8, 2023
Reiterates: Buy
Price Target: $150
Current: $2.15
Upside: +6,876.74%
Mar 17, 2023
Reiterates: Buy
Price Target: $22
Current: $1.39
Upside: +1,482.73%
Jan 24, 2023
Downgrades: Neutral
Price Target: $115 → $7
Current: $1.42
Upside: +392.96%
Dec 22, 2021
Maintains: Buy
Price Target: $12 → $11
Current: $0.78
Upside: +1,310.26%
Nov 24, 2021
Maintains: Buy
Price Target: $250 → $225
Current: $1.09
Upside: +20,542.20%
Jun 21, 2021
Assumes: Buy
Price Target: $25
Current: $4.68
Upside: +434.07%
Jan 7, 2021
Maintains: Buy
Price Target: $19 → $13
Current: $1.95
Upside: +566.67%